| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |